Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
28 results
D2.283 - Beyond the skin. A rare case of contact angioedema due to Methylisothiazolinone
D2.292 - Epinephrine Nasal Powder - a sustainable and reliable option for the treatment of anaphylaxis
D2.293 - Assessment of the Efficacy of Specific Immunotherapy After a Long Break in Asthmatic Patients
D2.278 - National Survey on Perioperative Hypersensitivity Reactions: Evaluating Practices and Challenges in Spanish Hospitals
D2.279 - In an emergency, can YOU really give that adrenaline pen? – the need for structured, further and improved training in Ireland
D2.282 - IgE-mediated anaphylaxis to quinine confirmed with a basophil activation test
D2.284 - Eat the fruit, do not swallow the seed: A rare case of Cucurbitaceae allergy causing anaphylaxis
D2.286 - A case of prawn induced FDEIA
D2.287 - Evaluation of NSAID Hypersensitivity in Children: A Retrospective Analysis
D2.288 - Idursulfase Hypersensitivity Reactions: Unpacking Immunological Mechanisms Beyond Clinical Manifestations
D2.289 - A Cardiovascular Enigma in the Emergency Room
D2.290 - Allergens involved in a case report of anaphylaxis to ginger (Zingiber officinale), a very rare but severe allergy
D2.291 - The level of knowledge of adolescent and young adults about food allergies and anaphylaxis: Key information that can save lives - a pilot study
D1.309 - Association of Antenatal Corticosteroids with Risk of Autoimmune Diseases in Children: a Nationwide Cohort Study
D1.308 - Case report: challenges in a long-term prophylaxis in hereditary angioedema (HAE)
D1.310 - Phenotypes of patients with Hereditary Angioedema (HAE): a case series
D1.311 - Treatment Dilemmas in CARMIL2 Deficiency
D1.312 - Acquired C1-inhibitor deficiency angioedema treated with lanadelumab: a case series
D1.313 - Inborn Error of Immunity Associated Inflammatory Bowel Disease at a Tertiary Care Center
D1.315 - Classifying the unclassifiable: diagnosis, characterization, and management of adults with unclassified primary antibody deficiency (unPAD)
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download